SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma

BACKGROUND: Spi-1 proto-oncogene (SPI1), which encodes an ETS-domain transcription factor, can activate gene expression in myeloid and lymphoid lineages. The role of SPI1 in the tumor immune microenvironment in clear cell renal cell carcinoma (ccRCC) remains unknown. In this study, we investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Huayi, Wang, Tao, Ye, Jiali, Yang, Yang, Huang, Xing, Lai, Dong, Lv, Zheng, Huang, Yan, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729685/
https://www.ncbi.nlm.nih.gov/pubmed/36477668
http://dx.doi.org/10.1007/s12672-022-00592-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729685/
https://www.ncbi.nlm.nih.gov/pubmed/36477668
http://dx.doi.org/10.1007/s12672-022-00592-0

Ejemplares similares